U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H25NO.BrH
Molecular Weight 352.309
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOMETHORPHAN HYDROBROMIDE

SMILES

Br.COC1=CC=C2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3C)C2=C1

InChI

InChIKey=MISZALMBODQYFT-FLCXFYETSA-N
InChI=1S/C18H25NO.BrH/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H/t15-,17+,18+;/m0./s1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C18H25NO
Molecular Weight 271.3972
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/26226106 | https://www.ncbi.nlm.nih.gov/pubmed/23628523 | https://www.ncbi.nlm.nih.gov/pubmed/24142584

Racemethorphan is racemic mixture of Dextromethorphan and Levomethorphan. Racemethorphan is listed under the Single Convention on Narcotic Drugs 1961 and is therefore listed in the United States as a Controlled Substance, specifically as a Narcotic in Schedule II. Dextromethorphan is a non-narcotic morphine derivative widely used as an antitussive. Dextromethorphan is a cough suppressant in many over-the-counter cold and cough medicines. In 2010, the FDA approved the combination product dextromethorphan/quinidine for the treatment of pseudobulbar affect. Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Levomethorphan is an opioid analgesic of the morphinan family that has never been marketed.

CNS Activity

Curator's Comment: https://www.ncbi.nlm.nih.gov/pubmed/16634036

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Over-the-counter medications for acute cough in children and adults in ambulatory settings.
2001
Dystonia as acute adverse reaction to cough suppressant in a 3-year-old girl.
2001
The placebo response to citric acid-induced cough: pharmacodynamics and gender differences.
2001
Pharmacological control of cough.
2001 Apr
Chromatographic analysis of phenethylamine-antihistamine combinations using C8, C18 or cyano columns and micellar sodium dodecyl sulfate-pentanol mixtures.
2001 Apr
Angle closure risk from proprietary medicines.
2001 Apr
Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.
2001 Apr
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. II. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2D6 inhibition assessment.
2001 Apr 5
A fast and efficient determination of amines and preservatives in cough and cold liquid and suspension formulations using a single isocratic ion-pairing high performance [correction of power] liquid chromatography method.
2001 Aug
The use of genetically engineered cells for assessing CYP2D6-related polymorphic effects.
2001 Aug-Oct
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.
2001 Dec
Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers.
2001 Feb
The safety of dextromethorphan in pregnancy : results of a controlled study.
2001 Feb
Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.
2001 Feb 15
The effect of the NMDA receptor blocker, dextromethorphan, on cribbing in horses.
2001 Jan
Epidemiologic analysis of prenatal exposure to cough medicines containing dextromethorphan: no evidence of human teratogenicity.
2001 Jan
Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects.
2001 Jan
Genetic polymorphism of CYP2D6 in Tamil population.
2001 Jan-Feb
Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
2001 Jul
NMDA receptor-mediated modulation of ventilation in obese Zucker rats.
2001 Jul
Increasing bioanalytical throughput using pcSFC-MS/MS: 10 minutes per 96-well plate.
2001 Jul 1
Clinical case discussion: anesthesia for Cesarean section in a parturient with a large intrathoracic tumour.
2001 Jun
Dextromethorphan affects cocaine-mediated behavioral pattern in parallel with a long-lasting Fos-related antigen-immunoreactivity.
2001 Jun 29
Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine.
2001 Jun 29
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats.
2001 Jun 29
Cytochrome P450 expression and related metabolism in human buccal mucosa.
2001 Mar
Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation.
2001 Mar
Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers.
2001 May
Dextromethorphan is an effective cough suppressant.
2001 May
Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.
2001 May
Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid.
2001 May
Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center.
2001 Oct 1
Dextromethorphan in pregnancy.
2001 Sep
The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites.
2002
Analgesic effects of dextromethorphan and morphine in patients with chronic pain.
2002 Apr
Modulation of human corticomotor excitability by somatosensory input.
2002 Apr 15
Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers.
2002 Feb
Development of a rapid and sensitive high-performance liquid chromatographic method to determine CYP2D6 phenotype in human liver microsomes.
2002 Feb
Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia.
2002 Jan
Dextromethorphan can produce false positive phencyclidine testing with HPLC.
2002 Jan
Inhibition kinetics of monoclonal antibodies against cytochromes P450.
2002 Jun
Treatment of codeine dependence with inhibitors of cytochrome P450 2D6.
2002 Jun
CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity.
2002 Mar
Selective suppression of late laryngeal adductor responses by N-methyl-D-aspartate receptor blockade in the cat.
2002 Mar
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration.
2002 Mar 1
The effects of concomitant administration of theophylline and toborinone on the pharmacokinetics of both compounds in poor and extensive metabolizers via CYP2D6.
2002 May
Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.
2002 May
Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
2002 May
Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial.
2002 May 11
Semi-automated liquid--liquid back-extraction in a 96-well format to decrease sample preparation time for the determination of dextromethorphan and dextrorphan in human plasma.
2002 May 25
Patents

Sample Use Guides

Levomethorphan (dissolved in a mixed solution of 5% Emulphor™ EL-620/5% ethanol/90% isotonic sodium chloride solution, 2.5 mg/mL, rat 4–6) was administered to male DA pigmented rats, which were 5 weeks old and around 90 g mean weight. The drugs were given once daily at 5 mg/kg by intraperitoneal injection for ten successive days.
Route of Administration: Intraperitoneal
Liver microsomes from individual male dark agouti (DA) rats (n=4, 6 weeks old, around 125 g mean weight) were prepared by ultracentrifugation. For the in vitro experiments with rat and human liver microsomes, the reaction mixture consisted of 0.1 M potassium phosphate buffer (pH 7.4) with an NADPH generating system (1.3 mM NADP, 3.3 mM G-6-P, 0.4 U/ mL G-6-PDH, 3.3 mM MgCl2), 50 μM substrate (dextromethorphan or levomethorphan), and 0.5 mg protein/mL microsomes (rat or human liver microsomes) in a final volume of 200 μL. Dextromethorphan and levomethorphan were dissolved in methanol, and the final concentration of the organic solvent was 0.1%. The incubation was started by adding the microsomal fraction and then continued for 0, 5, 10, or 20 min. The reaction was terminated by adding an equal volume of a mixed organic solution of 50% acetonitrile and 50% methanol, including 10 μM levallorphan (IS), and vigorous shaking.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:30:21 GMT 2025
Edited
by admin
on Mon Mar 31 22:30:21 GMT 2025
Record UNII
9YNW43KIJI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RO-1-5470/6
Preferred Name English
LEVOMETHORPHAN HYDROBROMIDE
MI  
Common Name English
2H-10,4A-IMINOETHANOPHENANTHRENE, 1,3,4,9,10,10A-HEXAHYDRO-6-METHOXY-11-METHYL-, HYDROBROMIDE
Common Name English
RO-1-7788
Code English
RACEMETHORPHAN-HYDROBROMIDE
Common Name English
(4BR,8AR,9R)-3-METHOXY-11-METHYL-6,7,8,8A,9,10-HEXAHYDRO-5H-9,4B-(EPIMINOETHANO)PHENANTHRENE HYDROBROMIDE
Systematic Name English
LEVOMETHORPHAN HYDROBROMIDE [MI]
Common Name English
MORPHINAN, 3-METHOXY-17-METHYL-, HYDROBROMIDE (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID80872363
Created by admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
PRIMARY
FDA UNII
9YNW43KIJI
Created by admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
PRIMARY
PUBCHEM
5486607
Created by admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
PRIMARY
MERCK INDEX
m6790
Created by admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
PRIMARY Merck Index
CAS
125-68-8
Created by admin on Mon Mar 31 22:30:21 GMT 2025 , Edited by admin on Mon Mar 31 22:30:21 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE